Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

 Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

Shots:

  • The Cobas MTB-RIF/INH test is a part of mycobacteria test menu which includes Cobas MTB and MAI tests for use on the Cobas 6800/8800 Systems, providing clinicians to speed up the treatment & reduces the spreading of an infection
  • The cobas MTB test allows the detection of Mycobacterium tuberculosis complex (MTBC) DNA, cobas MAI test allows direct detection and differentiation of M.avium and M. intracellulare DNA in symptomatic patients from their raw sputum, sputum sediment and bronchoalveolar lavage (BAL) sediment samples
  • The cobas MTB-RIF/INH test is used for the detection of mutation associated with resistance to antibiotics rifampicin and isoniazid in tuberculosis

Click here to read full press release/ article | Ref: Roche | Image: Glassdoor

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post